(Q33328585)

25 July 2017

1 reference

title

Antiphospholipid antibodies and thrombosis. (English)

1 reference

25 July 2017

0 references

1 reference

M Greaves

1

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

25 July 2017

1 reference

25 July 2017

volume

353

1 reference

25 July 2017

issue

9161

1 reference

25 July 2017

page(s)

1348-1353

1 reference

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Characterization and specificity of anti-endothelial cell membrane antibodies and their relationship to thrombosis in primary antiphospholipid syndrome (APS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Anti-endothelial cell antibodies to the endothelial hybridoma cell line (EAhy926) in systemic lupus erythematosus patients with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Inhibition of prostacyclin release by endothelial binding anticardiolipin antibodies in thrombosis-prone patients with systemic lupus erythematosus and the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Stimulation of von Willebrand factor antigen release by immunoglobulin from thrombosis prone patients with systemic lupus erythematosus and the anti-phospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

IgG from patients with antiphospholipid syndrome binds to platelets without induction of platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Anticardiolipin antibodies: clinical consequences of "low titers"

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Antiphospholipid Antibodies in Patients with Idiopathic Autoimmune Haemolytic Anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

HLA-DR7 in Association with Chlorpromazine-induced Lupus Anticoagulant (LA)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Prednisone and Aspirin in Women with Autoantibodies and Unexplained Recurrent Fetal Loss

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Combined use of aspirin and warfarin in primary prevention of ischemic heart disease in men at high risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Monitoring warfarin therapy in patients with lupus anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910362-8

7 January 2021

10.1016/S0140-6736(98)10362-8

Identifiers

DOI

1 reference

release_atdiu2tu2vd5zkohjkmhgbvvom

25 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/atdiu2tu2vd5zkohjkmhgbvvom

24 November 2022

mapped directly with Wikidata item

1 reference